Alphatec Holdings (ATEC) Cash & Equivalents (2010 - 2026)
Alphatec Holdings (ATEC) posted Cash & Equivalents of $139.9 million for Q1 2026, down 12.99% sequentially from $160.8 million in Q4 2025, and down 8.7% YoY from $153.2 million in Q1 2025.
Alphatec Holdings (ATEC) Cash & Equivalents (2010 - 2026) Analysis & Trends
Alphatec Holdings has reported Cash & Equivalents for 17 years, with the latest figure at $139.9 million in Q1 2026.
- Quarterly Cash & Equivalents fell 8.7% year-over-year to $139.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $139.9 million (down 8.7% YoY) and the FY2025 annual result came in at $160.8 million, up 15.82% from the prior year.
- Cash & Equivalents declined to $139.9 million in Q1 2026 per ATEC's latest filing, from $160.8 million in the prior quarter.
- Over five years, Cash & Equivalents peaked at $221.0 million in Q4 2023 and troughed at $81.0 million in Q3 2024.
- A 5-year average of $131.9 million and a median of $138.8 million in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents plunged 54.77% in 2022, then surged 160.9% in 2023.
- Over 5 years, Cash & Equivalents stood at $84.7 million in 2022, then jumped by 160.9% to $221.0 million in 2023, then slumped by 37.17% to $138.8 million in 2024, then increased by 15.82% to $160.8 million in 2025, then slipped by 12.99% to $139.9 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $139.9 million, $160.8 million, and $155.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Alphatec Holdings | 1.45 Bn | 1.34 Bn | 154.10 Mn | 118.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118.66 Mn |
| Mar 31, 2026 | 139.91 Mn |
| Dec 31, 2025 | 160.81 Mn |
| Sep 30, 2025 | 155.74 Mn |
| Jun 30, 2025 | 157.06 Mn |
| Mar 31, 2025 | 153.24 Mn |
| Dec 31, 2024 | 138.84 Mn |
| Sep 30, 2024 | 80.98 Mn |
| Jun 30, 2024 | 99.83 Mn |
| Mar 31, 2024 | 144.09 Mn |
| Dec 31, 2023 | 220.97 Mn |
| Sep 30, 2023 | 122.53 Mn |
| Jun 30, 2023 | 101.02 Mn |
| Mar 31, 2023 | 116.70 Mn |
| Dec 31, 2022 | 84.70 Mn |
| Sep 30, 2022 | 106.11 Mn |
| Jun 30, 2022 | 107.47 Mn |
| Mar 31, 2022 | 151.81 Mn |
| Dec 31, 2021 | 187.25 Mn |
| Sep 30, 2021 | 223.87 Mn |